Nicole Williams

Nicole Williams has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Intercept Pharmaceuticals, Inc. and Progenics Pharmaceuticals Inc. In total, 40 filings cover trades dated from 21 April 2009 to 20 November 2015.

The open-market record consists of 14 sales worth €2.8M, with no purchase. The rest of the record consists of 7 share grants and 19 option exercises. In 2015 alone, the filings show no purchases and 11 sales.

The latest filing, published on 23 November 2015, reports an option exercise of €8,908 in Intercept Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.